Arcellx (ACLX) Assets Average (2022 - 2025)
Arcellx's quarterly Assets Average came in at $630.0 million in Q4 2025, down 14.65% year-on-year from $738.1 million in Q4 2024, and down 1.18% quarter-over-quarter from $637.5 million in Q3 2025.
Arcellx has reported Assets Average for 4 years, with the latest figure at $630.0 million in Q4 2025.
- For the quarter ending Q4 2025, Assets Average fell 14.65% year-over-year to $630.0 million; the trailing twelve-month figure through Dec 2025 stood at $630.0 million (down 14.65% YoY), and the FY2025 full-year result was $657.7 million, down 14.39% from the prior year.
- Assets Average for Q4 2025 stood at $630.0 million, down from $637.5 million in the prior quarter.
- The five-year high for Assets Average was $802.4 million in Q1 2024, with the low at $187.9 million in Q1 2022.
- Average Assets Average over 4 years is $577.4 million, with a median of $631.8 million recorded in 2025.
- Year-over-year, Assets Average surged 149.29% in 2023 and slipped 16.3% in 2025.
- Tracing ACLX's Assets Average over 4 years: stood at $325.6 million in 2022, then soared by 121.05% to $719.7 million in 2023, then climbed by 2.56% to $738.1 million in 2024, then fell by 14.65% to $630.0 million in 2025.
- The last three Assets Average figures came in at $630.0 million (Q4 2025), $637.5 million (Q3 2025), and $633.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 26.03 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.71 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.05 Bn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 629.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 629.95 Mn |
| Sep 30, 2025 | 637.50 Mn |
| Jun 30, 2025 | 633.58 Mn |
| Mar 31, 2025 | 679.70 Mn |
| Dec 31, 2024 | 738.12 Mn |
| Sep 30, 2024 | 749.61 Mn |
| Jun 30, 2024 | 757.00 Mn |
| Mar 31, 2024 | 802.41 Mn |
| Dec 31, 2023 | 719.68 Mn |
| Sep 30, 2023 | 618.87 Mn |
| Jun 30, 2023 | 623.24 Mn |
| Mar 31, 2023 | 468.38 Mn |
| Dec 31, 2022 | 325.57 Mn |
| Sep 30, 2022 | 356.00 Mn |
| Jun 30, 2022 | 310.82 Mn |
| Mar 31, 2022 | 187.88 Mn |